Rifamate Related Clinical Trials
Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection [Terminated]
Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) [Recruiting]
TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance [Active, not recruiting]
A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case Contacts [Recruiting]
TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB [Completed]
High-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant Tuberculosis [Completed]
TBTC Study 26: Weekly RFP/INH for 3 mo. vs. Daily INH for 9 mo. for the Treatment of LTBI [Active, not recruiting]
Isoniazid Plus (Highly Active Antiretroviral Therapy) HAART to Prevent Tuberculosis (TB) in HIV-Infected Persons [Recruiting]
Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-Infected Children [Recruiting]
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin [Completed]
Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Persons in Botswana [Active, not recruiting]
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV [Recruiting]
TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment [Active, not recruiting]
TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection [Recruiting]
Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users [Active, not recruiting]
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) [Recruiting]
Treatment of Latent TB Infection for Jailed Persons [Active, not recruiting]
Treatment of Latent Tuberculosis Infection With Isoniazid [Recruiting]
A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy [Completed]
Randomized Trial for Pharmacogenomics-Based Tuberculosis Therapy (RT-PGTT) [Recruiting]
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis [Completed]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Active, not recruiting]
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection [Completed]
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection [Active, not recruiting]
Intensive Pharmacokinetics of the Nelfinavir-Rifabutin Interaction in Patients With HIV-Related Tuberculosis Treated With a Rifabutin-Based Regimen [Recruiting]
TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine [Completed]
A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients. [Completed]
The Treatment of Tuberculosis in HIV-Infected Patients [Completed]
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB [Completed]
Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [Completed]
Tuberculosis Prevention for HIV Infected Adults [Active, not recruiting]
NAT2 in Re-challenge of INH in Patients With Hepatitis [Recruiting]
EBA-Early Bactericidal Activity [Completed]
Tuberculosis Treatment Shortening Trial [Active, not recruiting]
TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz [Completed]
TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) [Recruiting]
TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment [Completed]
Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9) [Recruiting]
Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis [Completed]
Kidney Transplants in People With HIV Infection [Active, not recruiting]
A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis [Completed]
Preventive Therapy for Tuberculosis in HIV Infected Persons [Active, not recruiting]
Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients Indonesia [Completed]
Short Course Intermittent Regimens for the Treatment of HIV-Associated Tuberculosis [Active, not recruiting]
Cotrifazid Safety and Efficacy Against Malaria [Terminated]
TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis [Completed]
Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver Damage [Recruiting]
Adverse Reactions and Efficacy of Fixed-dose Combination Anti-tuberculosis (TB) Drugs [Recruiting]
Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament [Recruiting]
TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen [Completed]
Promoting Adherence to TB Regimens in Latino Adolescents [Completed]
Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk Adolescents
TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment [Completed]
|
